HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant mesothelioma induced in baboons by inhalation of amosite asbestos.

Abstract
Ten out of 12 South African baboons (Papio ursinus) survived exposure to amosite asbestos dust for periods ranging from 242 days to 898 days at an aerosol level ranging between 1,100 and 1,200 fibers per milliliter. After exposure, they were kept under observation until they died; the total residence time of amosite varied from 1.2-10.2 years. All underwent detailed postmortem necropsy examinations. All baboons had asbestosis. Five of the baboons developed malignant diffuse mesothelioma; three peritoneal, and two pleural with peritoneal invasion. These results indicate that amosite is highly carcinogenic. Since it is difficult to accomplish follow-up of persons exposed to amosite asbestos because of the geographic location of the amosite mines and mills in South Africa (a majority of the workers being migrant laborers from countries bordering on the Transvaal), it is therefore probable that cases of peritoneal mesothelioma have been missed. If human beings are likely to react to amosite as do baboons, epidemiological follow-up should include identification of abdominal as well as thoracic neoplasms.
AuthorsI Webster, B Goldstein, F S Coetzee, G C van Sittert
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 24 Issue 6 Pg. 659-66 (Dec 1993) ISSN: 0271-3586 [Print] United States
PMID8311096 (Publication Type: Journal Article)
Chemical References
  • Dust
  • Asbestos, Amosite
Topics
  • Animals
  • Asbestos, Amosite (adverse effects)
  • Atmosphere Exposure Chambers
  • Dust
  • Environmental Exposure
  • Male
  • Mesothelioma (etiology, pathology)
  • Papio
  • Peritoneal Neoplasms (etiology, pathology)
  • Pleural Neoplasms (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: